10th Edition of International conference on Biopolymers & Bioplastics
Biopolymer congress 2019, Top Bio polymer conferences in Singapore, Polymer Conference Euroscicon, List of Bio polymer conferences, List of polymer conferences, Upcoming Euroscicon Conferences,Polymer conferences in Euroscicon,Bioplastic Conference
Tackling industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical pricing landscape.
Highly Potent Active Pharmaceutical Ingredients (HPAPI) 2017
The inaugural Highly Potent Active Pharmaceutical Ingredients conference features key speakers of the industry presenting challenges, issues, innovation and new developments in various areas of HPAPI production, development and manufacturing.
SMi, the industry leaders in respiratory events, presents the 7th annual conference... COPD.19th & 20th Oct 2015 | Holiday Inn Regents Park Hotel, London UK
SMi's 4th annual Cancer Vaccines conference returns to London this autumn to strengthen knowledge of targeted immunotherapies taking the foreground in revolutionizing cancer vaccines.
SMi's 14th Annual Drug Design Conference will present attendees with an in-depth view into the developments and challenges within the Drug Design field | 16-17 Feb 2015, London UK
Latest on 112-based emergency call legislation and end to end security
Join SMi's Latest on 112-based emergency call legislation and end to end security for a digital society event on 21 Oct 14, to reflect on the status both of eCall and ERA GLONASS and end2end security
COPD 2014 will include topical and current sessions, such as Patient Care and The Future of COPD, as well as presenting attendees with in-depth information on exacerbation and comorbidities, clinical trial design, drug development and market access.
SMi is launching its inaugural Immunogenicity Conference, taking place in London on the 14th and 15th July. This two day event is designed to enhance SMi
Simulating Clinical Trials Using The FACTS Software Package
Join SMi's Simulating Clinical Trials Using the FACTS Software Package event on the 9 July in London, to hear how simulation of clinical trials is used in the trial design process and how it benefits.
This half day masterclass under the expertise of Klaus Rose Consulting, will provide a focus on: paediatric clinical trials, legislation considerations, Paediatric Investigation Plan and the impact of paediatric legislations in both US and EU
Join our Lyophilisation forum and gain insight into current successes and challenges that leading pharma and biotech organisations are facing in the freeze-drying field
Manufacturing Operation Strategy Planning for the Pharma/Biotech Industry
Join SMi's Manufacturing Operation Strategy Planning for the Pharma/Biotech Industry in 2014 event on the 7 July in London, to ensure your manufacturing network and capabilities grow efficiently
ADC Summit 2014Making your smart bomb smarter - creating innovative antibody-drug conjugates19th & 20th May 2014Holiday Inn Regents Park Hotel, London UK
Pain Therapeutics, Assess Alternative Approaches to Animal Models to Minimise the Translational Gap and Accelerate Market Access19th & 20th May 2014Holiday Inn Regents Park Hotel, London, UK
SMi present the 13th annual event:Advances & Progress in Drug DesignDelivering practical solutions to drug delivery challenges17-18 FEBRUARY 2014 | Marriott Regents Park Hotel, London UK
Attitudes across the Atlantic are slowly changing, and with the introduction of new legislation to help simplify biosimilar registration we take a look at how this has affected companies involved.
For those involved in the analysis of safety data this will provide insight into both what the expectations of the new legislation are as well as practical approaches to performing such activities. Essential whether a generic or innovator Company.
Getting your ADCs to the clinic: Considerations for early stage development
The development of existing or novel monoclonal antibodies as drug-conjugates to increase the targeted clinical effect of these proteins has rapidly increased in recent years.
The use of 'rapid testing' techniques is becoming more prevalent in microbiology laboratories, as they strive to produce faster and more accurate results to enhance product safety.
This fast-paced field and bring together senior representatives from industry and academia to discuss Statistical Issues in CADD, Binding Site Solvent Analysis, Structure-Based Lead Discovery and G-protein-coupled receptors.
the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.
From Obamacare to AMNOG, this event will provide a unique opportunity to understand HTA evolution from a payer perspective and learn how to plan and develop effective and appropriate pricing strategies.
...to speed your paediatric medicine to marketThe very different beasts of Intellectual Property, Ethics and Recruitment prowl the drug development process. All have one thing in common - hunger for deadlines.